Loading
Loading
Halozyme Therapeutics ceo salary
Helen I. Torley of HALOZYME THERAPEUTICS, INC. (HALO), received $23,166,223 ($23.2M) in total compensation for FY2025, up 81.8% from the prior year. Stock awards of $19,350,145 were the largest component. Figures come from HALOZYME THERAPEUTICS, INC.'s DEF 14A filed 23 Mar 2026 (accession 0001159036-26-000041).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001159036-26-000041). These figures come from HALOZYME THERAPEUTICS, INC.'s DEF 14A filed 23 Mar 2026 (accession 0001159036-26-000041).
| Component | Amount |
|---|---|
| Salary | $1,000,000 |
| Stock awards | $19,350,145 |
| Option awards | $1,650,014 |
| Cash incentive | $1,147,500 |
| Other | $18,564 |
| Total | $23,166,223 |
FAQ
See also: HALO ticker page